By combining technological advances and innovation, CROs can pass on the efficiencies obtained through reduced costs and development timelines to sponsors via their prices. This is increasingly important for CROs to remain competitive in the light of increased outsourcing of bioanalysis processes.

Link to the Contents page of the current issue of EPC.